Exagen (XGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov18

Exagen Receives Buy Rating from Two Investment Banks

12:02

Nov4

Exagen released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 17.24 M (forecast USD 16.9 M), actual EPS USD -0.31 (forecast USD -0.1585)

14:30

Exagen released FY2025 9 Months Earnings on November 4 Pre-Market (EST) with actual revenue of USD 49.94 M and EPS of USD -0.7216

14:30

Oct28

Exagen to release FY2025 Q3 earnings on November 4, pre-market EST, with forecast revenue of USD 16.9 M and EPS of USD -0.1585

00:28

Jul29

Exagen released FY2025 Q2 earnings on July 29 Pre-Market (EST), actual revenue USD 17.2 M (forecast USD 16.31 M), actual EPS USD -0.2105 (forecast USD -0.1533)

13:30

Exagen released FY2025 Semi-Annual earnings on July 29 Pre-Market (EST), actual revenue USD 32.7 M, actual EPS USD -0.413

13:30